BRPI1013179A2 - peptídeo sintético, métodos para detectar um anticorpo de proteína anti-citrulinado em uma amostra biológica, para realizar um ensaio para ajudar no diagnóstico ou prognóstico de artrite reumatóide, para melhorar a sensibilidade de diagnosticar ou prognosticar artrite reumatóide, ensaio para diagnosticar ou prognosticar artrite reumatóide, kit, e, método para identificar um peptídeo que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado - Google Patents
peptídeo sintético, métodos para detectar um anticorpo de proteína anti-citrulinado em uma amostra biológica, para realizar um ensaio para ajudar no diagnóstico ou prognóstico de artrite reumatóide, para melhorar a sensibilidade de diagnosticar ou prognosticar artrite reumatóide, ensaio para diagnosticar ou prognosticar artrite reumatóide, kit, e, método para identificar um peptídeo que é imunologicamente reativo com um anticorpo de proteína anti-citrulinadoInfo
- Publication number
- BRPI1013179A2 BRPI1013179A2 BRPI1013179A BRPI1013179A BRPI1013179A2 BR PI1013179 A2 BRPI1013179 A2 BR PI1013179A2 BR PI1013179 A BRPI1013179 A BR PI1013179A BR PI1013179 A BRPI1013179 A BR PI1013179A BR PI1013179 A2 BRPI1013179 A2 BR PI1013179A2
- Authority
- BR
- Brazil
- Prior art keywords
- rheumatoid arthritis
- assay
- protein antibody
- citrullinated protein
- peptide
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR122013006960-7A BR122013006960A2 (pt) | 2009-03-30 | 2010-03-26 | Peptídeo sintético que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado, seu uso e seu método de identificação, bem como kit compreendendo o referido peptídeo |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16484009P | 2009-03-30 | 2009-03-30 | |
US24349609P | 2009-09-17 | 2009-09-17 | |
US25505809P | 2009-10-26 | 2009-10-26 | |
PCT/US2010/028946 WO2010117694A2 (en) | 2009-03-30 | 2010-03-26 | Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1013179A2 true BRPI1013179A2 (pt) | 2019-09-24 |
Family
ID=42651163
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122013006960-7A BR122013006960A2 (pt) | 2009-03-30 | 2010-03-26 | Peptídeo sintético que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado, seu uso e seu método de identificação, bem como kit compreendendo o referido peptídeo |
BRPI1013179A BRPI1013179A2 (pt) | 2009-03-30 | 2010-03-26 | peptídeo sintético, métodos para detectar um anticorpo de proteína anti-citrulinado em uma amostra biológica, para realizar um ensaio para ajudar no diagnóstico ou prognóstico de artrite reumatóide, para melhorar a sensibilidade de diagnosticar ou prognosticar artrite reumatóide, ensaio para diagnosticar ou prognosticar artrite reumatóide, kit, e, método para identificar um peptídeo que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122013006960-7A BR122013006960A2 (pt) | 2009-03-30 | 2010-03-26 | Peptídeo sintético que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado, seu uso e seu método de identificação, bem como kit compreendendo o referido peptídeo |
Country Status (8)
Country | Link |
---|---|
US (2) | US8519096B2 (pt) |
EP (2) | EP2414390A2 (pt) |
AU (1) | AU2010234942B2 (pt) |
BR (2) | BR122013006960A2 (pt) |
CA (1) | CA2757444A1 (pt) |
IL (2) | IL225538A0 (pt) |
NZ (2) | NZ608489A (pt) |
WO (1) | WO2010117694A2 (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9404932B2 (en) * | 2007-11-05 | 2016-08-02 | Nordic Bioscience A/S | Pathology biomarker assay |
SI2280720T1 (sl) | 2008-03-27 | 2019-06-28 | Purdue Research Foundation | Sintetični peptidoglikani,ki vežejo kolagen, priprava in postopki uporabe |
EP2402368A1 (en) * | 2010-07-02 | 2012-01-04 | Toscana Biomarkers S.r.l. | Histone citrullinated peptides and uses thereof |
US10309974B2 (en) | 2010-11-12 | 2019-06-04 | Cedars-Sinai Medical Center | Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease |
EP2638401B1 (en) * | 2010-11-12 | 2017-02-15 | The Johns Hopkins University | Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease |
GB201101740D0 (en) | 2011-02-01 | 2011-03-16 | Haemostatix Ltd | Therapeutic agents with improved fibrinogen binding |
EP2694530B1 (en) * | 2011-04-05 | 2018-02-14 | Curara AB | Novel peptides that bind to types of mhc class ii and their use in diagnosis and treatment |
JP2014517832A (ja) * | 2011-05-10 | 2014-07-24 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 自己免疫疾患を治療するための方法及び医薬組成物 |
EP2527841A1 (en) * | 2011-05-25 | 2012-11-28 | Toscana Biomarkers S.r.l. | Methods for the diagnosis of rheumatoid arthritis |
EP2715360B1 (en) * | 2011-05-27 | 2016-08-17 | Nordic Bioscience A/S | Detection of diagnostic peptides |
KR101458100B1 (ko) * | 2012-01-13 | 2014-11-05 | 가톨릭대학교 산학협력단 | 류마티스 관절염 진단 키트 |
WO2013105721A1 (ko) * | 2012-01-13 | 2013-07-18 | 가톨릭대학교 산학협력단 | 류마티스 관절염 진단 키트 |
US20130274125A1 (en) * | 2012-04-16 | 2013-10-17 | Bio-Rad Laboratories Inc. | Multiplex immunoassay for rheumatoid arthritis and other autoimmune diseases |
GB201214007D0 (en) * | 2012-08-07 | 2012-09-19 | Scancell Ltd | Anti-tumour immune responses to modified self-epitopes |
WO2014141244A1 (en) * | 2013-03-12 | 2014-09-18 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Synthetic peptides for the treatment of autoimmune diseases |
JP6603650B2 (ja) | 2013-03-15 | 2019-11-06 | パーデュー・リサーチ・ファウンデーション | 細胞外マトリックス結合性合成ペプチドグリカン |
US11311598B2 (en) | 2013-09-13 | 2022-04-26 | Soligenix, Inc. | Peptides and analogs for use in the treatment of oral mucositis |
BR112016005557B1 (pt) * | 2013-09-13 | 2024-01-02 | Oreola Donini | Uso de peptídeos e peptídeos isolados |
US10772931B2 (en) | 2014-04-25 | 2020-09-15 | Purdue Research Foundation | Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction |
US10441644B2 (en) | 2015-05-05 | 2019-10-15 | The Regents Of The University Of California | H3.3 CTL peptides and uses thereof |
JP2018524575A (ja) | 2015-06-18 | 2018-08-30 | シーダーズ−サイナイ メディカル センター | 疾患の診断におけるシトルリン化の役割 |
GB201512703D0 (en) | 2015-07-20 | 2015-08-26 | Scancell Ltd | Anti-tumour immune responses to modified self-epitopes |
AU2018298224A1 (en) | 2017-07-07 | 2020-01-30 | Symic Ip, Llc | Synthetic bioconjugates |
CN110862450A (zh) * | 2018-08-28 | 2020-03-06 | 东莞光极生物科技有限公司 | 基于cii的环状多肽及其应用 |
CN110041404B (zh) * | 2019-04-08 | 2020-10-09 | 北京大学人民医院(北京大学第二临床医学院) | 瓜氨酸化抗原修饰肽及其应用 |
CN110456074B (zh) * | 2019-08-27 | 2022-06-03 | 广东菲鹏生物有限公司 | 瓜氨酸肽及其应用、类风湿关节炎的检测试剂与试剂盒 |
EP4021490A4 (en) * | 2019-08-30 | 2023-10-25 | Universidad De Chile | AUTOANTIGEN PEPTIDES (CALVICIFIV), PRESENTED BY TOLEROGENED DENTRIC CELLS, FOR THE PERSONALIZED TREATMENT OF RHEUMATOID ARTHRITIS |
CN113004421B (zh) * | 2021-02-18 | 2022-05-17 | 青岛硕景生物科技有限公司 | 一种检测抗瓜氨酸肽抗体的ccp抗原及其制备方法 |
EP4347029A1 (en) * | 2021-06-01 | 2024-04-10 | Lars Klareskog | Novel peptide mimics and their use |
CN115060897A (zh) * | 2021-07-01 | 2022-09-16 | 浙江大学 | 一种检测抗Prelamin A/C-IgG抗体的试剂盒 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
JP2002512939A (ja) * | 1997-11-28 | 2002-05-08 | イノジェネティックス・ナムローゼ・フェンノートシャップ | 診断および治療のためのツールとしての、リューマチ性関節炎の血清により認識されるシトルリン含有合成ペプチド |
EP1603937A2 (en) * | 2003-03-07 | 2005-12-14 | London Health Sciences Centre Research Inc. | Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases |
DE102005029845B4 (de) | 2005-06-27 | 2017-03-23 | Orgentec Diagnostika Gmbh | Verfahren zur Diagnose von rheumatischen Erkrankungen |
WO2009010409A1 (en) * | 2007-07-13 | 2009-01-22 | Celecure As | Novel inhibitor of angiogenesis |
-
2010
- 2010-03-26 AU AU2010234942A patent/AU2010234942B2/en not_active Ceased
- 2010-03-26 NZ NZ608489A patent/NZ608489A/en not_active IP Right Cessation
- 2010-03-26 BR BR122013006960-7A patent/BR122013006960A2/pt not_active IP Right Cessation
- 2010-03-26 BR BRPI1013179A patent/BRPI1013179A2/pt not_active IP Right Cessation
- 2010-03-26 CA CA2757444A patent/CA2757444A1/en not_active Abandoned
- 2010-03-26 WO PCT/US2010/028946 patent/WO2010117694A2/en active Application Filing
- 2010-03-26 NZ NZ595310A patent/NZ595310A/xx not_active IP Right Cessation
- 2010-03-26 EP EP10722838A patent/EP2414390A2/en not_active Withdrawn
- 2010-03-26 IL IL225538A patent/IL225538A0/en not_active IP Right Cessation
- 2010-03-26 EP EP16164584.1A patent/EP3070097A3/en not_active Withdrawn
-
2011
- 2011-09-21 US US13/239,329 patent/US8519096B2/en not_active Expired - Fee Related
- 2011-09-22 IL IL215337A patent/IL215337A/en not_active IP Right Cessation
-
2013
- 2013-07-26 US US13/952,499 patent/US20140170683A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NZ608489A (en) | 2014-08-29 |
AU2010234942B2 (en) | 2015-03-05 |
US8519096B2 (en) | 2013-08-27 |
EP3070097A2 (en) | 2016-09-21 |
IL215337A (en) | 2017-02-28 |
IL225538A0 (en) | 2013-06-27 |
CA2757444A1 (en) | 2010-10-14 |
NZ595310A (en) | 2013-05-31 |
EP2414390A2 (en) | 2012-02-08 |
AU2010234942A1 (en) | 2011-10-27 |
BR122013006960A2 (pt) | 2019-10-15 |
EP3070097A3 (en) | 2016-11-23 |
IL215337A0 (en) | 2011-12-29 |
WO2010117694A3 (en) | 2011-01-20 |
WO2010117694A2 (en) | 2010-10-14 |
US20120295280A1 (en) | 2012-11-22 |
US20140170683A1 (en) | 2014-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1013179A2 (pt) | peptídeo sintético, métodos para detectar um anticorpo de proteína anti-citrulinado em uma amostra biológica, para realizar um ensaio para ajudar no diagnóstico ou prognóstico de artrite reumatóide, para melhorar a sensibilidade de diagnosticar ou prognosticar artrite reumatóide, ensaio para diagnosticar ou prognosticar artrite reumatóide, kit, e, método para identificar um peptídeo que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado | |
NZ599105A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
BR112013003391A2 (pt) | biomarcadores de câncer pancreático e usos dos mesmos | |
BRPI0618713B8 (pt) | cardiolipina modificada e seus usos | |
EA201290311A1 (ru) | Факторы риска и прогнозирование инфаркта миокарда | |
EP3156925A3 (en) | Copd biomarker signatures | |
BRPI0923199B8 (pt) | método para determinar a presença de anticorpos de fixação de complemento | |
IN2014CN01787A (pt) | ||
BRPI0915619A2 (pt) | métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra | |
GB201009641D0 (en) | Methods of monitoring conditions by sequence analysis | |
NZ608384A (en) | Biomarkers of renal injury | |
BR112012017014A8 (pt) | métodos para detecção de anticorpos de vírus jc | |
AR103935A1 (es) | Métodos de detección y cuantificación de il-13 y sus usos en el diagnóstico y tratamiento de enfermedades asociadas a th-2 | |
EP3182126A3 (en) | Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome | |
DK2791675T3 (da) | Måling af autoantistoffer under lav ledeevne-betingelser | |
MX2009013009A (es) | Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico. | |
WO2008063663A3 (en) | Poly (ethylene glycol) anti-body detection assays and kits for performing thereof | |
ATE526584T1 (de) | Nachweisverfahren und nachweisreagens für autoimmune pankreatitis oder fulminanten typ-1- diabetes | |
SE0602683L (sv) | Diagnostisk metod | |
WO2012021741A3 (en) | Lateral flow assays for non-diagnostic analytes | |
WO2010006199A3 (en) | Immunoassays for the detection of anti -non-muscle myosin heavy chain (nmhc)-ii autoantibodies in cardiovascular diseases | |
BR112012009023A2 (pt) | método pra detecção. diferenciação e identificação de eubactérias específica de táxons em uma amostra biológica por meio de técnicas de análise de sequenciamento e kit | |
NZ605561A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
NZ601643A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
BR112015001587B8 (pt) | Método de ensaio de pcr para determinação da zigosidade de um gene rf4 em uma planta de milho |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: NESTEC S.A. (CH) |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |